Scientists uncover "genomic tug of war" that influences chemotherapy's effectiveness
 

Some patients with myelodysplastic syndromes, like acute myeloid leukemia, benefit from a chemotherapy drug called decitabine that stunts cancer growth. But many others are resistant to decatibine's effects or become resistant over time.

More...